View in EDS

Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.

Saved in:

Bibliographic Details
Title:	Purified herpes simplex thymidine kinase Retrovector particles. I. In vitro characterization, in situ transduction efficiency, and histopathological analyses of gene therapy-treated brain tumors.
Authors:	Kruse CA; University of Colorado Health Services Center, Department of Immunology, Denver 80262, USA., Roper MD, Kleinschmidt-DeMasters BK, Banuelos SJ, Smiley WR, Robbins JM, Burrows FJ
Source:	Cancer gene therapy [Cancer Gene Ther] 1997 Mar-Apr; Vol. 4 (2), pp. 118-28.
Publication Type:	Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
Journal Info:	Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	0929-1903